Home A case of PHACE syndrome with growth hormone deficiency and abnormal thyroid functions
Article
Licensed
Unlicensed Requires Authentication

A case of PHACE syndrome with growth hormone deficiency and abnormal thyroid functions

  • Chansuda Bongsebandhu-phubhakdi EMAIL logo , Therdpong Tempark , Ketsuda Jakchairoongruang and Vichit Supornsilpchai
Published/Copyright: September 2, 2019

Abstract

Background

PHACE syndrome is a rare vascular neurocutaneous disorder characterized by posterior fossa anomalies, hemangioma, arterial anomalies, cardiac anomalies and eye anomalies. Growth hormone deficiency (GHD) has been infrequently described.

Case presentation

We report a girl with PHACE syndrome. Endocrine abnormalities including abnormal thyroid functions and GHD have recently been described in similar cases.

Conclusions

This case suggests the necessity to screen pituitary functions in all patients with PHACE syndrome with abnormal hypothalamus and pituitary (HP) anatomy. Likewise, growth parameters and thyroid function test (TFT) should be monitored in all patients with PHACE syndrome at regular intervals.

Acknowledgments

We thank our patient’s parents who provided information and investigation results from primary hospital.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission. CB: interpretation of data, conception and design, conduct the work, drafting and revising the article; TT: conception and design, conduct of the work, revising the article; KJ: conduct the work, drafting and revising the article; VS: conception and design, conduct of the work, revising the article.

  2. Research funding: Grants for Development of New Faculty Staff, Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Frieden IJ, Reese V, Cohen D. PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol 1996;132:307–11.10.1001/archderm.1996.03890270083012Search in Google Scholar PubMed

2. Garzon MC, Epstein LG, Heyer GL, Frommelt PC, Orbach DB, et al. PHACE syndrome: consensus-derived diagnosis and care recommendations. J Pediatr 2016;178:24–33.e2.10.1016/j.jpeds.2016.07.054Search in Google Scholar PubMed PubMed Central

3. Blei F, McElhinney DB, Guarini A, Presti S. Cardiac screening in infants with infantile hemangiomas before propranolol treatment. Pediatr Dermatol 2014;31:465–70.10.1111/pde.12344Search in Google Scholar PubMed

4. Haggstrom AN, Lammer EJ, Schneider RA, Marcucio R, Frieden IJ. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 2006;117:698–703.10.1542/peds.2005-1092Search in Google Scholar PubMed

5. Bongsebandhu-phubhakdi C, Tempark T, Supornsilpchai V. Endocrine manifestations of PHACE syndrome. J Pediatr Endocrinol Metab 2019;32:797–802.10.1515/jpem-2019-0126Search in Google Scholar PubMed

6. Denzer F, Denzer C, Lennerz BS, Bode H, Wabitsch M. A case of phace syndrome and acquired hypopituitarism? Int J Pediatr Endocrinol 2012;2012:20.10.1186/1687-9856-2012-20Search in Google Scholar PubMed PubMed Central

7. Goddard DS, Liang MG, Chamlin SL, Svoren BM, Spack NP, et al. Hypopituitarism in PHACES Association. Pediatr Dermatol 2006;23:476–80.10.1111/j.1525-1470.2006.00287.xSearch in Google Scholar PubMed

8. Uihlein LC, Garzon MC, Goodwin G, Liang MG. Growth hormone replacement in patients with PHACE association and hypopituitarism. Pediatr Dermatol 2014;31:337–40.10.1111/pde.12306Search in Google Scholar PubMed

9. Carinci S, Tumini S, Consilvio NP, Cipriano P, Di Stefano A, et al. A case of congenital hypothyroidism in PHACE syndrome. J Pediatr Endocrinol Metab 2012;25:603–5.10.1515/jpem-2012-0002Search in Google Scholar PubMed

Received: 2019-03-18
Accepted: 2019-06-10
Published Online: 2019-09-02
Published in Print: 2019-11-26

©2019 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Hypo- and hyperthyroidism in early life – new developments
  4. Letters to the Editor
  5. Optic nerve sheath diameter appraisal in children affected by diabetic ketoacidosis
  6. Optic nerve sheath diameter ultrasound measurement to evaluate cerebral edema in children with diabetic ketoacidosis
  7. Original Articles
  8. Novel ABCD1 gene mutations in Iranian pedigrees with X-linked adrenoleukodystrophy
  9. Phenylketonuric patients represent their disease
  10. Mapping of IDUA gene variants in Pakistani patients with mucopolysaccharidosis type 1
  11. Genetic testing of two Pakistani patients affected with rare autosomal recessive Fanconi-Bickel syndrome and identification of a novel SLC2A2 splice site variant
  12. Sex differences in infant body composition emerge in the first 5 months of life
  13. Characterization of the duration of treatment with diazoxide in infants with prolonged hyperinsulinism (PHI)
  14. Clinical, biochemical and gender characteristics of 97 prepubertal children with premature adrenarche
  15. The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling
  16. The role of vitamin D replacement therapy in serum FGF23 concentration in children with myelomeningocele compared with healthy children – a preliminary study
  17. Genetic analyses in a cohort of Portuguese pediatric patients with congenital hypothyroidism
  18. Congenital hypothyroidism in preterm infants: a 3- to 8-year longitudinal study in southern Thailand
  19. Case Reports
  20. A case of PHACE syndrome with growth hormone deficiency and abnormal thyroid functions
  21. A novel DCAF17 homozygous mutation in a girl with Woodhouse-Sakati syndrome and review of the current literature
  22. Acquired von Willebrand’s syndrome caused by primary hypothyroidism in a 5-year-old girl
  23. Double variants in TSHR and DUOX2 in a patient with hypothyroidism: case report
Downloaded on 21.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2019-0078/html?lang=en
Scroll to top button